# BAC in Patient With Alzheimer's Disease or Vascular Dementia

> **NCT02467413** · PHASE2 · WITHDRAWN · sponsor: **Charsire Biotechnology Corp.**

## Conditions studied

- Alzheimer's Disease
- Vascular Dementia

## Interventions

- **DRUG:** BAC
- **OTHER:** BAC Matched Vehicle

## Key facts

- **NCT ID:** NCT02467413
- **Lead sponsor:** Charsire Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01-30
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn before participants were enrolled.
- **Last updated:** 2022-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467413, "BAC in Patient With Alzheimer's Disease or Vascular Dementia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02467413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*